Metastatic Colorectal Cancer Market is Driven by Targeted Therapies

добавлена новая статья Health

2025-05-14 09:55:31 -

The metastatic colorectal cancer (mCRC) market encompasses a broad spectrum of treatment modalities designed to improve survival outcomes and quality of life for patients with advanced disease. Key products include monoclonal antibodies, tyrosine kinase inhibitors, immunotherapies, and personalized combination regimens that target specific genetic mutations such as KRAS, NRAS, and BRAF. These...

0 Комментарии 0 Поделились 630 Просмотры 0 предпросмотр